Expand ATOS Menu
ATOS MENU

ATOS Latest Press Releases

-- January 30, 2025 --

Atossa Therapeutics Responds to PTAB Ruling on U.S. Patent No. 11,572,334 and Announces the Issuance of U.S. Patent No. 12,201,591 Globe Newswire 8:17 AM

-- January 23, 2025 --

Atossa Therapeutics Issues Letter to Shareholders Highlighting 2024 Accomplishments and Outlook for 2025 Globe Newswire 8:15 AM

-- January 6, 2025 --

Atossa Therapeutics Applauds U.S. Surgeon General's Advisory Highlighting Alcohol as a Leading Preventable Cause of Breast Cancer Globe Newswire 9:00 AM

-- December 12, 2024 --

Atossa Therapeutics to Present Poster Describing the Discovery of Molecules Synergistic with (Z)-endoxifen for the Treatment of Breast Cancer at the 2024 San Antonio Breast Cancer Symposium Globe Newswire 8:15 AM

-- December 11, 2024 --

Atossa Therapeutics Announces Full Results from Phase 2 KARISMA-Endoxifen Study Demonstrating Statistically Significant Reductions in Mammographic Breast Density Globe Newswire 8:15 AM

-- December 10, 2024 --

Atossa Therapeutics to Present Pharmacokinetic and Tolerability Data from Phase 2 EVANGELINE Trial at the 2024 San Antonio Breast Cancer Symposium Globe Newswire 9:05 AM

-- December 9, 2024 --

Atossa Therapeutics Presents Data from Study Investigating Anti-Cancer Activity of (Z)-Endoxifen-Related Compounds at AACR Special Conference in Cancer Research Globe Newswire 8:15 AM

-- November 21, 2024 --

Atossa Therapeutics to Present Poster on (Z)-Endoxifen at AACR Special Conference in Cancer Research Globe Newswire 8:30 AM

-- November 20, 2024 --

Atossa Therapeutics Announces Five Abstracts Highlighting (Z)-Endoxifen Research Accepted for Presentation at the 2024 San Antonio Breast Cancer Symposium Globe Newswire 8:30 AM

-- November 12, 2024 --

Atossa Therapeutics Announces Third Quarter 2024 Financial Results and Provides Corporate Update Globe Newswire 8:30 AM

-- November 5, 2024 --

Atossa Therapeutics Appoints Claudia Lopez, DVM, MSc, as Vice President, Clinical Product Development Globe Newswire 8:30 AM

-- November 4, 2024 --

Atossa Therapeutics Reports Positive KARISMA-Endoxifen Trial Results: Globe Newswire 6:30 AM

-- October 31, 2024 --

Atossa Therapeutics Releases Promising Preliminary Analysis Demonstrating (Z)-Endoxifen's Potential to Rapidly Reduce Ki-67 and Tumor Volume in ER+/HER2- Breast Cancer Globe Newswire 8:15 AM

-- October 21, 2024 --

Atossa Therapeutics to Participate in Fireside Chat with Karolinska Institute at BIO-EUROPE 2024 to Discuss a Unique Swedish American Collaboration to Prevent Breast Cancer Globe Newswire 8:30 AM

-- October 14, 2024 --

Atossa Therapeutics to Present at the 2024 Maxim Healthcare Virtual Summit Globe Newswire 5:08 PM

-- October 1, 2024 --

Atossa Therapeutics Commemorates Breast Cancer Awareness Month, Highlighting the Need for Innovation Across the Breast Cancer Treatment Continuum Globe Newswire 8:30 AM

-- September 10, 2024 --

Atossa Therapeutics Announces Support of Final Rule from FDA Requiring Patient Notification of Breast Density, a Critical Step in Addressing a Known Risk Factor for Breast Cancer Globe Newswire 8:30 AM

-- September 3, 2024 --

Atossa Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference Globe Newswire 8:30 AM